ALEXANDRIA, Va., June 18 -- United States Patent no. 12,325,703, issued on June 10, was assigned to CGeneTech (Suzhou China) Co. Ltd. (Jiangsu, China).
"Fused ring compound as FGFR and VEGFR dual inhibitor" was invented by Zhengxia Chen (Shanghai), Haizhong Tan (Shanghai), Yang Zhang (Shanghai), Jian Li (Shanghai) and Shuhui Chen (Shanghai).
According to the abstract* released by the U.S. Patent & Trademark Office: "A fused ring compound as an FGFR and VEGFR dual inhibitor. Particularly, disclosed is a compound represented by formula (III) or a pharmaceutically acceptable salt thereof."
The patent was filed on June 12, 2020, under Application No. 17/596,531.
*For further information, including images, charts and tables, please visit: ht...